SHIVALIK
Shivalik Rasayan Limited
NSEFiling History
Recent corporate announcements and filings for SHIVALIK
Ownership
Neutral
2026-08-24 12:36
- Intimation of sale of 25,000 Equity Shares by Mr. Sanjay Bansal, a former Director (Connected Person), on August 21, 2026.
- The shares were sold from the open market for Rs. 68,31,455.
- Post-sale, his holding is 25,000 shares (0.16%).
Governance
Positive
2026-08-22 11:54
- EGM held on August 20, 2026, approved two special resolutions.
- Resolution 1: Issuance of up to 3,72,000 Equity Shares to the "Public" category on preferential basis (99.9989% in favour).
- Resolution 2: Issuance of up to 9,48,000 Fully Convertible Warrants to "Promoter and Promoter Group" and "Public" category on preferential basis (99.9997% in favour).
- Both resolutions passed with requisite majority.
Governance
Positive
2026-08-22 10:23
- EGM held on August 20, 2026, for Shivalik Rasayan Limited.
- Shareholders approved the issuance of up to 3,72,000 Equity Shares on a preferential basis to the 'Public' category.
- Shareholders also approved the issuance of up to 9,48,000 Fully Convertible Warrants on a preferential basis to 'Promoter and Promoter Group' and 'Public' categories.
- Both resolutions were passed with overwhelming majority, receiving over 99.99% votes in favour.
Governance
Neutral
2026-08-21 12:00
- An Extra-Ordinary General Meeting (EGM) of Shivalik Rasayan Limited was held on August 20, 2026.
- The EGM discussed special resolutions for issuing up to 3,72,000 equity shares to the public and up to 9,48,000 fully convertible warrants to promoter and public categories, both on a preferential basis.
- Voting results will be communicated to the exchanges upon receipt of the scrutinizer's report.
Business Update
Neutral
2026-08-14 17:37
- Submission of the Business Responsibility & Sustainability Report (BRSR) for the financial year ending March 31, 2026.
- The report details policies and initiatives on social, environmental, and economic responsibilities.
- Key business activities: Agrochemicals (88.85% turnover), Pharma API (5.31%), and R&D (5.83%).
- The company outlines material risks (Health & Safety, Business Ethics, Compliance) and their mitigation strategies.
- Opportunities in employee development, process innovation, and waste management are also identified.
Governance
Positive
2026-08-14 17:29
- The 48th Annual General Meeting (AGM) will be held on Monday, September 28, 2026, at 1:00 P.M. IST.
- The Record Date for determining eligible members for dividend payment is Monday, September 21, 2026.
- If approved at the AGM, the dividend will be paid on and from Thursday, October 15, 2026.
Financials
Positive
2026-08-14 17:24
- Q1 FY27 Consolidated Revenue ₹96.34 Cr vs ₹89.31 Cr (▲7.9% YoY)
- EBITDA ₹11.18 Cr vs ₹10.98 Cr (▲1.8% YoY)
- PAT ₹4.50 Cr vs ₹2.82 Cr (▲59.6% YoY)
- EBITDA Margin 11.6% vs 12.3% (▼70bps)
- Board recommended a Final Dividend of 10% or ₹0.50 per equity share for FY 2025-26, subject to AGM approval.
- The 48th AGM will be held on September 28, 2026.
Ownership
Neutral
2026-08-05 15:48
- Intimation of sale of 50,000 equity shares by Mr. Sanjay Bansal, a former Director (Connected Person).
- Shares were sold from the open market on August 05, 2026, for a value of ₹1,24,87,360.
- Post-sale, his holding reduced from 0.63% to 0.32%.
Financials
Positive
2026-07-30 11:38
CRITICAL RED FLAG DETECTED
- Consolidated Revenue ₹102.82Cr vs ₹69.39Cr (▲48% YoY)
- EBITDA ₹12.43Cr vs ₹5.76Cr (▲116% YoY)
- PAT ₹7.17Cr vs ₹5.19Cr (▲38% YoY)
- EBITDA Margin 11.86% vs 7.67% (▲419bps)
Ownership
Neutral
2026-07-28 16:14
- Mr. Sanjay Bansal, a former Director (Connected Person), sold 60,000 equity shares of Shivalik Rasayan Limited from the open market.
- The transaction was valued at ₹1,54,55,262 and occurred between July 24-28, 2026, reducing his holding from 1.01% to 0.63%.
Governance
Positive
2026-07-27 18:17
- Extra Ordinary General Meeting (EGM) scheduled for August 20, 2026.
- To approve preferential issue of up to 372,000 Equity Shares at ₹250/share (totaling ₹9.30 Cr).
- To approve preferential issue of up to 948,000 Fully Convertible Warrants at ₹250/warrant (totaling ₹23.70 Cr).
- Remote e-voting period: August 17-19, 2026.
Ownership
Positive
2026-07-23 18:12
- Board approved preferential issue of up to 3,72,000 equity shares (₹9.30 Cr) and 9,48,000 warrants (₹23.70 Cr) at ₹250 each.
- An Extra-Ordinary General Meeting (EGM) is scheduled for August 20, 2026, to seek shareholder approval for these issues.
Ownership
Positive
2026-07-23 17:49
- Board approved preferential issue of up to 3,72,000 equity shares at ₹250/share (total ₹9.3 Cr) to the public category.
- Also approved preferential issue of up to 9,48,000 fully convertible warrants at ₹250/warrant (total ₹23.7 Cr) to promoter/public categories.
- An Extra-Ordinary General Meeting (EGM) is scheduled for August 20, 2026, to seek shareholder approval for these issues.
Routine
Neutral
2026-06-24 14:26
- Intimation of trading window closure for Insiders.
- Effective from July 01, 2026, ahead of Un-Audited Financial Results for the quarter ended June 2026.
- Will remain closed until two days post-results declaration.
Ownership
Neutral
2026-06-04 13:01
- Former Director, Mr. Sanjay Bansal, sold 40,000 equity shares of Shivalik Rasayan Limited on June 2, 2026, for ₹1,02,41,453.75 via open market.
- His shareholding reduced from 1.27% (2,00,000 shares) to 1.01% (1,60,000 shares).
Financials
Positive
2026-05-27 17:18
CRITICAL RED FLAG DETECTED
Consolidated Revenue ₹104.73Cr vs ₹75.10Cr (▲39.45% YoY), EBITDA ₹12.43Cr vs ₹5.76Cr (▲115.80% YoY), PAT ₹7.17Cr vs ₹5.19Cr (▲38.19% YoY). EBITDA Margin 11.86% vs 7.67% (▲419bps). The Board also recommended a final dividend of ₹0.50 per equity share for FY 2025-26.
Routine
Neutral
2026-04-13 14:31
New Filing detected. See link for details.
Financials
Negative
2026-02-13 17:18
Consolidated Revenue ₹83.21Cr vs ₹86.91Cr (▼4.25% YoY), EBITDA ₹10.32Cr vs ₹13.31Cr (▼22.34% YoY), PAT ₹3.67Cr vs ₹6.94Cr (▼47.09% YoY). EBITDA Margin 12.41% vs 15.31% (▼290bps).
Financials
Negative
2026-02-13 17:16
Consolidated Revenue ₹8,203.75 Lakhs vs ₹8,530.61 Lakhs (▼3.83% YoY), EBITDA ₹1,032.39 Lakhs vs ₹1,330.66 Lakhs (▼22.41% YoY), PAT ₹366.95 Lakhs vs ₹693.79 Lakhs (▼47.09% YoY). EBITDA Margin 12.58% vs 15.60% (▼302bps).